1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Thyroid carcinoma overall incidence and mortality, stratified by patient sex and tumor characteristics
Year
1990 1993 2000 2006 2009
Total incidence 5.43 5.58 7.53 11.1 14.1
Total mortality 0.37 0.49 0.55 0.48 0.5
Incidence in subgroups 
    Sex 
        Male 2.87 3.58 3.98 5.74 6.84
        Female 7.89 7.54 10.98 16.35 21.2
    Tumor histology 
        Papillary 4.29 (79%) 4.31 (77%) 6.36 (84%) 9.51 (86%) 12.47 (88%)
        Follicular 0.75 (14%) 0.83 (15%) 0.79 (10%) 1.09 (10%) 1.14 (8%)
        Medullary 0.13 (2%) 0.2 (4%) 0.19 (3%) 0.2 (2%) 0.21 (1%)
        Anaplastic 0.04 (1%) 0.09 (2%) 0.05 (1%) 0.06 (1%) 0.11 (1%)
        Other 0.22 (4%) 0.16 (3%) 0.14 (2%) 0.23 (2%) 0.18 (1%)
    Tumor size 
        <10 mm 0.71 (13%) 0.82 (15%) 1.47 (20%) 3.15 (28%) 4.38 (31%)
        10–14 mm 0.57 (10%) 0.55 (10%) 0.85 (11%) 1.6 (14%) 2.15 (15%)
        15–19 mm 0.55 (10%) 0.61 (11%) 0.89 (12%) 1.36 (12%) 1.86 (13%)
        20–29 mm 0.99 (18%) 1.04 (19%) 1.35 (18%) 1.79 (16%) 2.14 (15%)
        30–39 mm 0.51 (9%) 0.56 (10%) 0.66 (9%) 0.96 (9%) 1.22 (9%)
        ≥40 mm 0.61 (11%) 0.68 (12%) 0.86 (11%) 1.4 (13%) 1.57 (11%)
    Tumor stage 
        Localized or unstaged 2.97 (55%) 3.05 (55%) 4.49 (60%) 7.12 (64%) 9.09 (64%)
        Regional 2.04 (38%) 2.14 (38%) 2.61 (35%) 3.49 (31%) 4.33 (31%)
        Distant 0.42 (8%) 0.4 (7%) 0.42 (6%) 0.49 (4%) 0.68 (5%)
Note:—Incidence is expressed as the number of new cases per 100,000 people per year. The numbers in parentheses are percentages of the total incidence. The years 1993–2006 represent the period for which annual CT volume data are also available.